Navigation Links
GenomeQuest, Inc. Announces Digital Gene Expression Solution Within Its Sequence Data Management Platform
Date:5/5/2009

DigEx Solution offers completely interactive gene-level database to explore, understand, manage, and share next-generation sequencing DigEx runs.

WESTBOROUGH, Mass., May 5 /PRNewswire/ -- GenomeQuest, Inc., the leader in sequence data management, today announced that it has released a Digital Gene Expression Workflow designed to enable researchers working with next-generation sequencing data. The Digital Gene Expression Workflow is the second such workflow to be delivered by GenomeQuest (March 2, 2009 - GenomeQuest Launches Rapid Annotation Pipeline) that allows researchers to analyze hundreds of millions of raw reads and explore the results in their web browser within the GenomeQuest web-application.

"Our customers are excited by the exploratory nature of our Digital Gene Expression workflow, which enables them to interact directly with their data," said Richard Resnick, VP of Software and Services. "Of course they get intuitive gene expression reports, an integrated gene viewer, drill downs on individual alignments, and clickable, queryable gene and annotation databases. But they also get the innate ability to use and share previous experiments as the annotation for future experiments."

The Digital Gene Expression Workflow is fully cross-platform, working with Illumina, SOLiD, Helicos and 454 reads. The workflow is enabled by GenomeQuest's high-speed commercial-grade algorithms, data management structure, and powerful compute cluster to deliver results within hours.

Visit the GenomeQuest website for a recorded demonstration and the Application Note - http://www.genomequest.com/solutions/Digital_Gene_Expression.html

About GenomeQuest, Inc.

GenomeQuest, Inc. is the leading sequence data management company providing applications and services to search, manage, analyze and mine the world's sequence data. The company's flagship product, GenomeQuest(TM), is a web-based sequence data management and analysis platform that enables users to exploit genomic information resources including next-generation sequencing tools and worldwide biological sequence reference databases. GenomeQuest's customers leverage high-speed algorithms and sophisticated analysis and reporting to transform sequence data into functional knowledge, on-demand. GenomeQuest delivers genomic data access, management, and utility to over 160 leading life science companies worldwide.

GenomeQuest, Inc., is headquartered in Westborough, Massachusetts. For more information, call (508) 616-0100, or visit www.genomequest.com.


'/>"/>
SOURCE GenomeQuest, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Ambry Genetics Announces the Addition of Array CGH Services Through Partnership With Baylor College of Medicine
2. NanoLogix Inc. to Exhibit at The American Society for Microbiology (ASM) General Meeting in Philadelphia; Announces Two New Patents
3. Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate
4. SENOMYX ANNOUNCES NESTLES SELECTION OF A NEW FLAVOR INGREDIENT FOR EVALUATION OF COMMERCIAL POTENTIAL
5. American Oriental Bioengineering Announces May 2009 Conference Participation
6. Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma
7. Providence-Based NABsys, Inc., Announces $4 Million Equity Financing
8. 3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor
9. Rigel Announces First Quarter 2009 Financial Results
10. Novavax Announces Release Date of 2009 First Quarter, Financial Results and Investor Conference Call
11. Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... , June 23, 2016 On Wednesday, ... at 4,833.32, down 0.22%; the Dow Jones Industrial Average edged ... closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on ... ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals ... (NASDAQ: BIND ). Learn more about these stocks ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers ... The result of a collaboration among several companies with expertise in toolholding, cutting ...
(Date:6/22/2016)... , June 22, 2016 Cell Applications, ... allow them to produce up to one billion ... lot within one week. These high-quality, consistent stem ... preparing cells and spend more time doing meaningful, ... a proprietary, high-volume manufacturing process that produces affordable, ...
Breaking Biology Technology:
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):